3-Methoxy-a-methylbenzeneethanamine
Brand names,
3-Methoxy-a-methylbenzeneethanamine
Analogs
3-Methoxy-a-methylbenzeneethanamine
Brand Names Mixture
- Adderall (amphetamine + dextroamphetamine)
- Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
- Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
3-Methoxy-a-methylbenzeneethanamine
Chemical_Formula
C9H13N
3-Methoxy-a-methylbenzeneethanamine
RX_link
http://www.rxlist.com/cgi/generic3/adderallxr.htm
3-Methoxy-a-methylbenzeneethanamine
fda sheet
3-Methoxy-a-methylbenzeneethanamine
msds (material safety sheet)
3-Methoxy-a-methylbenzeneethanamine
Synthesis Reference
U. S. Pat. 1,879,003, (1932)
3-Methoxy-a-methylbenzeneethanamine
Molecular Weight
135.206 g/mol
3-Methoxy-a-methylbenzeneethanamine
Melting Point
Volatizes slowly at room temperature
3-Methoxy-a-methylbenzeneethanamine
H2O Solubility
Slightly
3-Methoxy-a-methylbenzeneethanamine
State
Solid
3-Methoxy-a-methylbenzeneethanamine
LogP
1.799
3-Methoxy-a-methylbenzeneethanamine
Dosage Forms
Capsules
3-Methoxy-a-methylbenzeneethanamine
Indication
For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.
3-Methoxy-a-methylbenzeneethanamine
Pharmacology
Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.
3-Methoxy-a-methylbenzeneethanamine
Absorption
It forms easily absorbed molecules that are highly lipid soluble
3-Methoxy-a-methylbenzeneethanamine
side effects and Toxicity
LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.
3-Methoxy-a-methylbenzeneethanamine
Patient Information
Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.
3-Methoxy-a-methylbenzeneethanamine
Organisms Affected
Humans and other mammals